Yale researchers have found a way to spot new viruses
By screening negative nasal swabs for a specific antiviral protein, a Yale team believes we may be able to find hidden viruses before they emerge.
First-of-its-kind nasal vaccine for COVID-19 deployed in India
India has begun deploying a nasal vaccine for COVID-19 that may be able to prevent infections, not just limit their severity.
I’ve had COVID and am constantly getting colds. Did COVID harm my immune system?
Does COVID somehow weaken the immune system to make us more prone to other infectious diseases? Here's what scientists know.
Newly discovered antibody neutralizes all variants of the coronavirus
Using modified mouse models originally designed for HIV, researchers have discovered an antibody that stops all known strains of COVID-19.
Researchers may have created a universal coronavirus vaccine
All currently licensed COVID-19 vaccines target the spike protein’s S1 region, which is prone to mutations. We need a universal vaccine.
MIT just created a test that can tell if you’re immune to COVID-19
MIT researchers have developed an easy-to-use test that may be able to predict an individual’s immune response to SARS-CoV-2.
Long COVID-19 and chronic conditions after viral infections may stem from an overactive immune response
Understanding the immunological mechanisms underlying long COVID-19 is the first step to addressing a quickly worsening public health problem.
Nasal COVID-19 vaccines prepare for infection right where it starts – in your nose and throat
Intranasal vaccines are best suited to protect against pathogens that enter through the nose, like the flu or the coronavirus.
Will new vaccines be better at fighting coronavirus variants?
New virus-based vaccines could play an important role in generating a long-lasting, broad immunity against a rapidly mutating virus.
Moderna expects to have Omicron booster ready by Fall 2022
Moderna expects to have an Omicron booster that combines its original COVID-19 vaccine with one targeting the variant ready by Fall 2022.
America’s “Test to Treat” has failed. Here’s how to fix it.
So far, Test to Treat has largely failed to get antivirals for COVID-19 to patients that need them — but the initiative can still be fixed.
WeChat users try to keep Shanghai lockdown protest video ahead of censors
WeChat users have turned to all manner of tricks in a cat-and-mouse game with CCP censors to keep a video about the Shanghai lockdown online.
Strange treatment may restore sense of smell after COVID
Philadelphia doctors are treating COVID patient’s loss of smell with plasma-soaked sponges. But whether it is working or not still needs to be sniffed out.
New UV light safely kills 98% of airborne pathogens indoors
Far-UVC light — a type of ultraviolet light that isn’t harmful to human health — killed 98% of airborne microbes indoors in a new study.
One shot of this COVID-19 drug reduces risk of death by 60%
In-development COVID-19 drug Peginterferon Lambda reduced risk of hospitalization or lengthy emergency room visits by 50% in a phase 3 trial.
New antibody treatment against Omicron gets emergency approval
A new monoclonal antibody treatment effective against Omicron has received emergency authorization weeks after two others were banned.
Researchers are testing neural stimulation as a long COVID treatment
Small pilot trials of two different types of external electrical brain stimulation suggest the technique may work as a long COVID treatment.
How can Moderna and Pfizer adjust vaccines for omicron? A microbiologist answers 5 questions
If the omicron variant of the coronavirus is different enough from the original variant, existing vaccines might not be as effective.
Pfizer’s antiviral pill cuts COVID-19 hospitalization, death by 89%
Pfizer’s antiviral pill to treat COVID-19 cut the risk of hospitalization or death by 89%, according to early results from a phase 2/3 trial.
Merck is making its COVID-19 antiviral pill more affordable to low-income countries
Drug maker Merck has agreed to license a promising antiviral pill to treat COVID-19 to low- and middle-income countries for free.
FDA panel recommends COVID-19 vaccine for 5 to 11 year olds (Updated)
An FDA panel voted to authorize Pfizer’s COVID-19 vaccine for kids ages 5 to 11. Here’s what you need to know about it.
Pill to treat COVID-19 cuts risk of hospitalization or death in half
A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.
FDA approves COVID-19 boosters for seniors, high-risk groups (Updated)
The FDA has expanded its authorization of COVID-19 boosters of Pfizer’s vaccine to include seniors and people in high-risk populations.
Study: COVID-19 booster shots dramatically reduce infection risk
A large COVID-19 booster shot study in Israel found that a third dose significantly increased seniors’ protection against the coronavirus.
Antibody cocktail highly effective at preventing COVID-19
An antibody cocktail developed by biopharmaceutical company AstraZeneca was highly effective at preventing symptomatic COVID-19 infections.
Pfizer’s shot is the first FDA-approved COVID-19 vaccine
Pfizer’s shot has become the first FDA-approved COVID-19 vaccine, making the transition from emergency use authorization on August 23.
Beyond Sunday Service: How one Montgomery church is bringing health equity to their community
In partnership with Chan Zuckerberg Initiative
A grassroots approach to vaccine education is happening in the heart of the civil rights movement in Alabama. Does this church hold the key to overcoming medical mistrust?
New treatment may prevent heart damage from COVID-19
An experimental drug that stopped the coronavirus from entering cells in heart organoids may be able to prevent heart damage from COVID-19.
Pfizer has manufactured the first batch of Delta variant vaccines
Pharma giant Pfizer has already developed and manufactured ingredients for a COVID-19 vaccine targeting the highly contagious Delta variant.
Door-to-door vaccination campaign reaches the most vulnerable
In partnership with Chan Zuckerberg Initiative
An equitable door-to-door vaccination campaign might be just what it takes to help the U.S.’s most vulnerable communities fight COVID-19.
CRISPR halts coronavirus transmission in human cells
A new CRISPR treatment that halted coronavirus transmission in human cells could be the easy-to-distribute COVID-19 drug the world needs.
“LEGO-like” vaccine protects mice from COVID, SARS, MERS, and variants
Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.
Moderna COVID-19 vaccine 2.0: Lower dose, fewer side effects
Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.
Mass vaccination experiment was a huge success in Brazil
A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.
Ohio announces $1M vaccine lottery, shots surge 33%
Ohio’s vaccine lottery, which will give five vaccinated residents $1 million each, appears to have sparked the desired increase in new vaccinations.
Would you spray this DIY COVID-19 vaccine up your nose?
Makers of a DIY COVID-19 vaccine are talking to governments about launching human challenge trials to quickly and cheaply find out if the vaccine is effective.
All adults in the US are now eligible for COVID-19 vaccines
In the U.S., anyone over the age of 16 is now eligible for COVID-19 vaccines — a major milestone along the path to herd immunity.
Inhaled asthma drug accelerates COVID-19 recovery at home
Budesonide — a cheap, inhaled asthma drug that can be self-administered — appears to shorten at-risk COVID-19 patients’ recovery times.
Hologram pizzeria brings virtual happy hour to a new level
Virgin Media’s hologram dining experience, Two Hearts Pizzeria, let people feel like they were sharing a meal with loved ones located in another city.
Pfizer’s COVID-19 vaccine 100% effective in adolescent study
Pfizer’s COVID-19 vaccine was reportedly 100% effective in a trial involving more than 2,000 adolescents between the ages of 12 and 15.
A common virus may be the key to a COVID vaccine for young children
Researchers have reverse-engineered a common children’s virus to show the spike protein, potentially leading to a new COVID vaccine for young children.
Facebook’s vaccine hunters are helping Americans get vaccinated
COVID-19 shots are here, but making an appointment can be a pain. Vaccine hunters are playing matchmaker on Facebook to get jabs into arms.
Vaccine delivery truck brings COVID-19 shots right to you
Startup AYRO’s all-electric vaccine delivery truck could bring COVID-19 vaccines to people without access to reliable transportation.
FDA: One-shot COVID-19 vaccine is safe and effective
FDA experts confirm that Johnson and Johnson’s one-shot COVID-19 vaccine is safe and effective, putting it a step closer to authorization.
World’s first COVID-19 human challenge study is a go
Researchers have gotten the green light to deliberately infect people with the coronavirus as part of the world’s first COVID-19 human challenge study.
Study: Strong immunity without Pfizer vaccine’s second dose
The Pfizer vaccine's second dose might not be as necessary as thought — and ultra-cold storage of the COVID-19 vaccine might not be necessary at all.